Press Releases

EXTON, Pa. , May 15, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2017 dividend of $0.13 per share. The dividend will be paid on August 2, 2017 to shareholders of record as of July 19, 2017 .

EXTON, Pa. , May 3, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that Fran DeGrazio , Vice President Scientific Affairs and Technical Services, and Diane Paskiet , Director,

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 27, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2017 and updated financial guidance for the full-year 2017.  First-Quarter 2017 Highlights

EXTON, Pa. , April 13, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2017 financial results before the market opens on Thursday, April 27, 2017 ,

- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 16, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2016 and provided detailed financial guidance for full-year 2017.  Executive

EXTON, Pa. , Feb. 2, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2016 financial results before the market opens on Thursday,

Scientific and educational sessions to feature West's innovation and regulatory expertise EXTON, Pa. , Feb. 1, 2017 /PRNewswire/ -- Booth #H26 -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today introduced two new

EXTON, Pa. , Dec. 28, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of the Company's business at the 35 th Annual J.P. Morgan Healthcare Conference , San Francisco, CA , at 3:30 p.m.

Flynn recognized in the Female Executive of the Year category for her instrumental role in developing and executing West's market-led, long-term strategic plan EXTON, Pa. , Dec. 20, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for

Company honored with 2016 India Pharma Award and Irish Medtech Excellence Award; West's SmartDose® platform takes second place in Medicine Maker Innovation Awards EXTON, Pa. , Dec. 15, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for

EXTON, Pa. , Dec. 14, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2017 dividend of $0.13 per share. The dividend will be paid on February 1, 2017 , to shareholders of record as of January 18,

Adds to Growing Manufacturing Footprint in Ireland DUBLIN , Nov. 29, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the completion of a 60,000 square foot expansion at its contract

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 27, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter 2016, updated financial guidance for the full-year 2016, introduced sales growth outlook for

Two co-presentations with Amgen highlight West's approach to delivering innovative drug delivery solutions for its customers HUNTINGTON BEACH, Calif. , Oct. 17, 2016 /PRNewswire/ --  (Booth #504) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for

EXTON, Pa. , Oct. 13, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third quarter 2016 financial results before the market opens on Thursday, October 27,

EXTON, Pa. , Sept. 26, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed David A. Montecalvo to serve as Senior Vice President, Global Operations and Supply Chain,

EXTON, Pa. , Sept. 12, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors elected Paolo Pucci to fill the vacancy following the retirement of Anthony Welters .    Mr. Pucci, 54, is Chief Executive Officer of ArQule, Inc.

EXTON, Pa. , Sept. 2, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at three investor conferences in September.  Management will present at the Baird 2016 Global Healthcare Conference, New York,

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 28, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second quarter 2016 and updated financial guidance for the full-year 2016.  Second Quarter 2016 Highlights

EXTON, Pa. , July 14, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second quarter 2016 financial results before the market opens on Thursday, July 28, 2016 , and

On-body Infusor with Prefilled Cartridge to Deliver Monthly Single Dose of Repatha® (evolocumab) EXTON, Pa. , July 11, 2016 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the U.S.

EXTON, Pa. , July 5, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2016 dividend of $0.12 per share. The dividend will be paid on August 3, 2016 , to shareholders of record as of July 20, 2016

New, high-quality plungers launched at the 2016 BIO International Convention EXTON, Pa. , June 7, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the availability of the 1-3mL NovaPure®

EXTON, Pa. , June 1, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will present an overview of West's business at the Jefferies Healthcare Conference in New York, NY , on Wednesday, June 8, 2016 at 11:30 a.m. EDT .

EXTON, Pa. , May 4, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at two investor conferences in May. Management will present at the Bank of America Merrill Lynch 2016 Health Care

- Reports Quarterly Sales of $362 Million, Constant-Currency Sales Growth of 10.5% and Adjusted Diluted EPS of $0.53. - Raises Lower-end of Full-year 2016 Sales and Adjusted EPS Guidance Ranges. - Conference Call Scheduled for 9 a.m. EDT Today. EXTON, Pa.

EXTON, Pa. , April 25, 2016 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced a strategic investment in NanoPass Technologies Ltd. This investment will provide West with access to NanoPass'

EXTON, Pa. , April 14, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first quarter 2016 financial results before the market opens on Thursday, April 28, 2016 ,

EXTON, Pa. , March 4, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2016 dividend of $0.12 per share. The dividend will be paid on May 4, 2016 , to shareholders of record as of April 20, 2016

John Paproski to Retire After 36 Years of Service EXTON, Pa. , March 1, 2016 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced Eric Resnick has been appointed to serve as Vice President and

EXTON, Pa. , Feb. 25, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the Company will host an Analyst and Investor Day on Thursday, March 10, 2016 , from 8:30 a.m. to 12 p.m.

Reports Quarterly Sales of $359.7 Million and Adjusted Diluted EPS of $0.47 -- Annual Sales of $1.4 Billion Generated Adjusted Diluted EPS of $1.83 in 2015 -- Reaffirms 2016 Guidance for 6% to 8% Growth in Net Sales at Constant Currency -- Provides Full-Year 2016 Adjusted Diluted EPS Guidance in

High-performance containment system selected by top biotech company EXTON, Pa. , Feb. 12, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that global biotechnology leader Amgen Inc.

EXTON, PA -- ( Marketwired ) -- 02/11/16 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and full year 2015 financial results before the market opens on Thursday, February 18, 2016 , and will follow with a conference call to discuss the results

EXTON, PA -- ( Marketwired ) -- 02/03/16 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at the LEERINK Partners 5 th Annual Global Healthcare Conference, New York, NY at 10:40 a.m.

Presentation at Drug Delivery Partnerships 2016 will offer best practices for effective patient onboarding with wearable self-injection systems EXTON, Pa. , Jan. 20, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug

EXTON, Pa. , Jan. 12, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced a change to its organization and reporting structure that will support the Company in its next phase of growth and

EXTON, PA -- ( Marketwired ) -- 01/06/16 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business and outlook at the 34rd Annual J.P. Morgan Healthcare Conference , San Francisco, CA at 3:00 p.m.

EXTON, PA -- ( Marketwired ) -- 12/17/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2016 dividend of $0.12 per share. The dividend will be paid on February 3, 2016 to shareholders of record as of January 20,

EXTON, Pa. , Nov. 19, 2015 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed George L. Miller to serve as Senior Vice President, General Counsel and Corporate Secretary,